Back

Effect of bivalent RSV prefusion F protein-based vaccine on myocarditis and pericarditis: a prespecified safety analysis of the DAN-RSV trial

30 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: New insights into inflammatory myocardial diseases Myocarditis ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Marat Yafasov

Gentofte Hospital - Copenhagen University Hospital, Hellerup (Denmark)

6 More presentations in this session

Presentation thumbnail
Genetically determined cardio-inflammatory phenotypes in recurrent pericarditis: a systematic review and meta-analysis
Doctor F. Veneziano (Groningen, NL)
Presentation thumbnail
Risk stratification in myocarditis: retrospective application of the 2025 ESC Guidelines (GL) criteria in a large, well-characterized cohort with Inflammatory Myopericardial Disease (IMPD)
Doctor L. Manfrin (Trieste, IT)
Abstract Slides Video
Presentation thumbnail
Prevalence and severity spectrum of lymphocytic myocarditis in a dilated cardiomyopathy phenotype endomyocardial biopsy cohort, classified by the Seaport criteria
Doctor S. EBEOGLU (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
Long-term outcomes of cardiac sarcoidosis in southern Europe: A 16-year cohort
Doctor M. Salvador (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Prognostic implications of interventricular septal wall thickness in cardiac sarcoidosis
Doctor K. Takamura (Kochi, JP)
Abstract Slides Video

Access the full session

Session thumbnail
New insights into inflammatory myocardial diseases

The Event

Event poster

ESC Congress 2026

30 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
DAN-RSV: RSVpreF vaccine for preventing cardiorespiratory hospitalisations
29 August 2026
thumbnail
Congress Presentation
Safety of COVID-19 vaccines regarding cardiovascular events: a systematic review and meta-analysis
1 September 2024
thumbnail
Congress Presentation
Anakinra versus placebo double blind Randomized controlled trial for the treatment of Acute MyocarditIS
30 August 2024
thumbnail
Congress Presentation
Simultaneous vaccination against influenza and respiratory syncytial virus in high-risk heart failure patients
17 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources